良國作郎
liked
Elon has repeatedly posted on X asking if he wants a smartphone, but will a smartphone be made.
Translated
7
3
$NEBIUS (NBIS.US)$
Wait, don't rush!!
Wait, don't rush!!
Translated
2
Translated
6
良國作郎
voted
$Ichigo (2337.JP)$
I started seeing advertisements for strawberries everywhere, so I looked it up and found out that telework is outdated, and urban offices are also experiencing a rapid recovery.
I tried logging in at 353, baby.
I started seeing advertisements for strawberries everywhere, so I looked it up and found out that telework is outdated, and urban offices are also experiencing a rapid recovery.
I tried logging in at 353, baby.
Translated
3
1
良國作郎
reacted to
$Arqit Quantum (ARQQ.US)$
Today's decisive word from the Jin Sen fan might be the key. Since there are only grasshoppers 🦗, it will collapse in an instant. You should sell without regrets. I have already sold about 60 percent.
Today's decisive word from the Jin Sen fan might be the key. Since there are only grasshoppers 🦗, it will collapse in an instant. You should sell without regrets. I have already sold about 60 percent.
Translated
2
$Tesla (TSLA.US)$
There seems to be a bad guy coming to the rice market as a whole.
All hands, full evacuation!!!
There seems to be a bad guy coming to the rice market as a whole.
All hands, full evacuation!!!
Translated
2
良國作郎
reacted to
良國作郎
liked
$CRISPR Therapeutics (CRSP.US)$
I bought it yesterday based on the determination that it was near the lowest price.
Among the stocks handling CrisperCas9, it is currently considered the best.
However, if considering it as a fundamental treatment for genetic deficiencies, it is worth keeping in mind that Japan's Universities hold a patent for CrisperCas3, which may have higher potential in the future.
I bought it yesterday based on the determination that it was near the lowest price.
Among the stocks handling CrisperCas9, it is currently considered the best.
However, if considering it as a fundamental treatment for genetic deficiencies, it is worth keeping in mind that Japan's Universities hold a patent for CrisperCas3, which may have higher potential in the future.
Translated
5